申请人:AGIOS PHARMACEUTICALS, INC
公开号:US20160264621A1
公开(公告)日:2016-09-15
Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1 comprising administering to a subject in need thereof a compound described here.
提供了一种治疗具有IDH1突变等特征的癌症的方法,包括向需要该治疗的受试者施用此处描述的化合物。